Dementia

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dementia, Cognitive Impairment, Mild, Dementia, Vascular Trial in Farmington, New Haven (Referral for Cognitive Stimulation

Enrolling by invitation
  • Dementia
  • +8 more
  • Referral for Cognitive Stimulation Therapy
  • No change to Standard of Care
  • Farmington, Connecticut
  • +1 more
May 16, 2023

Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)

Recruiting
  • Alzheimer Disease
  • +2 more
  • Birmingham, Alabama
  • +143 more
Jan 31, 2023

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))

Suspended
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +34 more
Jan 10, 2023

Cognitive Impairment, Emergency Care, Dementia Trial in New Haven, Chicago (PD4ED 3-step intervention (ED assessment, outpatient

Completed
  • Cognitive Impairment
  • +3 more
  • PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)
  • New Haven, Connecticut
  • +1 more
Nov 1, 2022

Families Coping Together With Alzheimer's Disease

Recruiting
  • Family Research
  • Dementia
    • New Haven, Connecticut
      Yale school of Public Health
    Oct 7, 2021

    Alzheimer's Disease, Dementia Trial in Worldwide (EVP-6124)

    Terminated
    • Alzheimer's Disease
    • Dementia
    • Phoenix, Arizona
    • +85 more
    May 2, 2016

    (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

    Completed
    • Alzheimer's Disease
    • Dementia
    • Placebo
    • donepezil (Aricept)
    • New Haven, Connecticut
      Pfizer Investigational Site
    Feb 10, 2011

    Alzheimer, Dementia Trial in United States (MPC-7869)

    Completed
    • Alzheimer Disease
    • Dementia
    • Alabaster, Alabama
    • +132 more
    May 3, 2009

    Alzheimer, Dementia Trial in Worldwide (MPC-7869)

    Terminated
    • Alzheimer Disease
    • Dementia
    • Phoenix, Arizona
    • +91 more
    Aug 1, 2008